Top 20 Cancer Therapy Brands Forecast: Industry Research Report

Top 20 Cancer Therapy Brands Forecast

Published Date: October 2009

Published By: Datamonitor

Page Count: 125

Order Code: R313-55088

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

Introduction

The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven major pharmaceutical markets in 2008, growing at a CAGR of 17.4% between 2005 and 2008.

Reasons to Purchase

Quantify the performance of each of leading 20 cancer therapies in the seven major markets over the period 2008 to 2018
Assess the changing key opportunities and threats both for currently marketed and pipeline cancer therapy brands
Identify the leading brands in this market over the next 10 years and understand the key factors driving their success

Please note: this is delivered as a Zip file.

Similar Products

• Snapshots US Pharmaceuticals 2009

Published Nov 2009 by Snapdata International Group

• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

Published Nov 2009 by Aruvian's R'search

• Pharmaceutical Industry in Mexico

Published Nov 2009 by Aruvian's R'search

• Pharmaceuticals Industry Report

Published Nov 2009 by Plimsoll Publishing Ltd.

• Antipsychotics Market Forecast

Published Oct 2009 by Datamonitor